학술논문
Sofosbuvir and Ribavirin Therapy for Children Aged 3 to <12 Years With Hepatitis C Virus Genotype 2 or 3 Infection
Document Type
article
Author
Rosenthal, Philip; Schwarz, Kathleen B; Gonzalez‐Peralta, Regino P; Lin, Chuan‐Hao; Kelly, Deidre A; Nightingale, Scott; Balistreri, William F; Bansal, Sanjay; Jonas, Maureen M; Massetto, Benedetta; Brainard, Diana M; Hsueh, Chia‐Hsiang; Shao, Jiang; Parhy, Bandita; Davison, Suzanne; Feiterna‐Sperling, Cornelia; Gillis, Lynette A; Indolfi, Giuseppe; Sokal, Etienne M; Murray, Karen F; Wirth, Stefan
Source
Hepatology. 71(1)
Subject
Language
Abstract
Currently, the only approved hepatitis C virus (HCV) treatment for children aged